BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Clinical Outcome
12 results:

  • 1. [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].
    Hu SS; Wu YB; Zhu PP; Shi JM; Yu J; Zhao YM; Lai XY; Liu LZ; Fu HR; Huang H; Luo Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):992-1002. PubMed ID: 36709104
    [No Abstract]    [Full Text] [Related]  

  • 2. Prognostic role of controlling nutritional status score in hematological malignancies.
    Zhang Y; Chen Q; Lu C; Yu L
    Hematology; 2022 Dec; 27(1):653-658. PubMed ID: 35622088
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. clinical outcome of patients diagnosed with myelodysplastic syndrome-unclassifiable (mds-U): single center experience.
    Baidoun F; Chen D; Patnaik M; Gangat N; Begna K; Elliott M; Hogan W; Litzow M; Al-Kali A
    Leuk Lymphoma; 2019 Oct; 60(10):2483-2487. PubMed ID: 31609151
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease.
    Kinsella FAM; Inman CF; Gudger A; Chan YT; Murray DJ; Zuo J; McIlroy G; Nagra S; Nunnick J; Holder K; Wall K; Griffiths M; Craddock C; Nikolousis E; Moss P; Malladi R
    Leuk Res; 2019 Aug; 83():106173. PubMed ID: 31276965
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study.
    Mądry K; Lis K; Biecek P; Młynarczyk M; Rytel J; Górka M; Kacprzyk P; Dutka M; Rodzaj M; Bołkun Ł; Krochmalczyk D; Łątka E; Drozd-Sokołowska J; Waszczuk-Gajda A; Knopińska-Posłuszny W; Kopińska A; Subocz E; Masternak A; Guzicka-Kazimierczak R; Gil L; Machowicz R; Biliński J; Giebel S; Czerw T; Dwilewicz-Trojaczek J
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):264-274.e4. PubMed ID: 30898482
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The impact of HLA-C matching depends on the C1/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation.
    Fischer JC; Kobbe G; Enczmann J; Haas R; Uhrberg M
    Immunogenetics; 2012 Dec; 64(12):879-85. PubMed ID: 22923051
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies.
    Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Ostojić G; Tatomirovic Z; Ljubenov M; Marjanović S; Malesević M
    Vojnosanit Pregl; 2011 Dec; 68(12):1026-32. PubMed ID: 22352263
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Granulocytic sarcoma: 32 cases and review of the literature.
    Paydas S; Zorludemir S; Ergin M
    Leuk Lymphoma; 2006 Dec; 47(12):2527-41. PubMed ID: 17169797
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Internal tandem duplications of Flt3 gene (Flt3/ITD) predicts a poor post-remission outcome in adult patients with acute non-promyelocytic leukemia.
    Ciolli S; Vannucchi AM; Leoni F; Nozzoli C; Longo G; Salati A; Pancrazzi A; Bianchi L; Gigli F; Bosi A
    Leuk Lymphoma; 2004 Jan; 45(1):73-8. PubMed ID: 15061200
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
    Hansen PB; Penkowa M; Johnsen HE
    Leuk Lymphoma; 1998 Feb; 28(5-6):491-500. PubMed ID: 9613978
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants.
    Harbott J; Mancini M; Verellen-Dumoulin C; Moorman AV; Secker-Walker LM
    Leukemia; 1998 May; 12(5):823-7. PubMed ID: 9593287
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
    Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
    Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.